α-Lipoic acid reduces fatty acid esterification and lipogenesis in adipocytes from overweight/obese subjects

Obesity

Volumn 22, Issue 10, 2014, Pages 2210-2215

  Fernández Galilea, Marta ^a   Pérez Matute, Patricia ^b   Prieto Hontoria, Pedro L ^a,c   Sáinz, Neira ^a   López Yoldi, Miguel ^a   Houssier, Marianne ^d   Martínez, J Alfredo ^a,e   Langin, Dominique ^d,f   Moreno Aliaga, María J ^a,e  

^a UNIVERSITY OF NAVARRA   (Spain)

^b CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

^c Facultad de Estudios del Patrimonio Cultural   (Chile)

^d Departments of Clinical Biochemistry and Sports Medicine   (France)

^e Instituto de Salud Carlos III   (Spain)

^f TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE 1; COMPOUND C; DIACYLGLYCEROL ACYLTRANSFERASE 1; ENZYME INHIBITOR; FATTY ACID SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; THIOCTIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; FATTY ACID;

ABDOMINAL SUBCUTANEOUS FAT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; FATTY ACID ESTERIFICATION; FATTY ACID METABOLISM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID METABOLISM; LIPOGENESIS; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; SIGNAL TRANSDUCTION; ADIPOCYTE; CELL CULTURE; DRUG EFFECTS; ESTERIFICATION; METABOLISM; PATHOLOGY; SUBCUTANEOUS FAT;

ADIPOCYTES; CELLS, CULTURED; DOWN-REGULATION; ESTERIFICATION; FATTY ACIDS; FEMALE; HUMANS; LIPID METABOLISM; LIPOGENESIS; OBESITY; OVERWEIGHT; SUBCUTANEOUS FAT; THIOCTIC ACID; TRIGLYCERIDES;

EID: 84907611172     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20846     Document Type: Article

References (40)

1. Prieto-Hontoria PL, Perez-Matute P, Fernandez-Galilea M, Martinez JA, Moreno-Aliaga MJ. Effects of lipoic acid on AMPK and adiponectin in adipose tissue of low- and high-fat-fed rats. Eur J Nutr 2013; 52:779-787.
2. Prieto-Hontoria PL, Perez-Matute P, Fernandez-Galilea M, Barber A, Martinez JA, Moreno-Aliaga MJ. Lipoic acid prevents body weight gain induced by a high fat diet in rats: Effects on intestinal sugar transport. J Physiol Biochem 2009; 65:43-50.
3. Carbonelli MG, Di Renzo L, Bigioni M, Di Daniele N, De Lorenzo A, Fusco MA. Alpha-lipoic acid supplementation: A tool for obesity therapy? Curr Pharm Des 2010; 16:840-846.
4. Kim E, Park DW, Choi SH, Kim JJ, Cho HS. A preliminary investigation of alpha-lipoic acid treatment of antipsychotic drug-induced weight gain in patients with schizophrenia. J Clin Psychopharmacol 2008; 28:138-146.
5. Koh EH, Lee WJ, Lee SA, et al. Effects of alpha-lipoic Acid on body weight in obese subjects. Am J Med 2011; 124:85 e81-88
6. Kim MS, Lee KU. Role of hypothalamic 5′-AMP-activated protein kinase in the regulation of food intake and energy homeostasis. J Mol Med (Berl) 2005; 83:514-520.
7. Fernandez-Galilea M, Perez-Matute P, Prieto-Hontoria P, Martinez JA, Moreno-Aliaga MJ. Effects of lipoic acid on apelin in 3T3-L1 adipocytes and in high-fat fed rats. J Physiol Biochem 2011; 67:479-486.
8. Fernandez-Galilea M, Perez-Matute P, Prieto-Hontoria PL, Martinez JA, Moreno-Aliaga MJ. Effects of lipoic acid on lipolysis in 3T3-L1 adipocytes. J Lipid Res 2012; 53:2296-2306.
9. Febbraio M, Hajjar DP, Silverstein RL. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 2001; 108:785-791.
10. Letexier D, Pinteur C, Large V, Frering V, Beylot M. Comparison of the expression and activity of the lipogenic pathway in human and rat adipose tissue. J Lipid Res 2003; 44:2127-2134.
11. Lodhi IJ, Yin L, Jensen-Urstad AP, et al. Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARgamma activation to decrease diet-induced obesity. Cell Metab 2012; 16:189-201.
12. Marcelino H, Veyrat-Durebex C, Summermatter S, et al. A role for adipose tissue de novo lipogenesis in glucose homeostasis during catch-up growth: A Randle cycle favoring fat storage. Diabetes 2013;62:362-372.
13. Chen WL, Kang CH, Wang SG, Lee HM. alpha-Lipoic acid regulates lipid metabolism through induction of sirtuin 1 (SIRT1) and activation of AMP-activated protein kinase. Diabetologia 2012; 55:1824-1835.
14. Valdecantos MP, Perez-Matute P, Gonzalez-Muniesa P, Prieto-Hontoria PL, Moreno-Aliaga MJ, Martinez JA. Lipoic acid administration prevents nonalcoholic steatosis linked to long-term high-fat feeding by modulating mitochondrial function. J Nutr Biochem 2012; 23:1676-1684.
15. Hulver MW, Berggren JR, Cortright RN, et al. Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab 2003; 284:E741-747.
16. Daval M, Foufelle F, Ferre P. Functions of AMP-activated protein kinase in adipose tissue. J Physiol 2006; 574:55-62.
17. Bijland S, Mancini SJ, Salt IP. Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation. Clin Sci (Lond) 2013; 124:491-507.
18. Nogalska A, Sucajtys-Szulc E, Swierczynski J. Leptin decreases lipogenic enzyme gene expression through modification of SREBP-1c gene expression in white adipose tissue of aging rats. Metabolism 2005; 54:1041-1047.
19. Smith SJ, Cases S, Jensen DR, et al. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat Genet 2000; 25:87-90.
20. Hou XG, Moser S, Sarr MG, Thompson GB, Que FG, Jensen MD. Visceral and subcutaneous adipose tissue diacylglycerol acyltransferase activity in humans. Obesity (Silver Spring) 2009; 17:1129-1134.
21. Yen CL, Stone SJ, Koliwad S, Harris C, Farese RV, Jr. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J Lipid Res 2008;49:2283-2301.
22. Stone SJ, Myers HM, Watkins SM, et al. Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J Biol Chem 2004; 279:11767-11776.
23. Suzuki R, Tobe K, Aoyama M, et al. Expression of DGAT2 in white adipose tissue is regulated by central leptin action. J Biol Chem 2005; 280:3331-3337.
24. Matsuda D, Tomoda H. DGAT inhibitors for obesity. Curr Opin Investig Drugs 2007; 8:836-841.
25. Butler JA, Hagen TM, Moreau R. Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion. Arch Biochem Biophys 2009; 485:63-71.
26. Garrido-Sanchez L, Vendrell J, Fernandez-Garcia D, et al. De novo lipogenesis in adipose tissue is associated with course of morbid obesity after bariatric surgery. PLoS One 2012; 7:e31280.
27. 2O. Am J Physiol Endocrinol Metab 2004; 286:E577-588.
28. Roberts R, Hodson L, Dennis AL, et al. Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia 2009; 52:882-890.
29. Dobrzyn P. Stearoyl-CoA desaturase in the control of metabolic homeostasis. Postepy Biochem 2012; 58:166-174.
30. Kim E, Lee JH, Ntambi JM, Hyun CK. Inhibition of stearoyl-CoA desaturase1 activates AMPK and exhibits beneficial lipid metabolic effects in vitro. Eur J Pharmacol 2011; 672:38-44.
31. Kadegowda AK, Burns TA, Pratt SL, Duckett SK. Inhibition of stearoyl-CoA desaturase 1 reduces lipogenesis in primary bovine adipocytes. Lipids 2013; 48:967-976.
32. Kim KH. Regulation of mammalian acetyl-coenzyme A carboxylase. Annu Rev Nutr 1997; 17:77-99.
33. Peng IC, Chen Z, Sun W, et al. Glucagon regulates ACC activity in adipocytes through the CAMKKbeta/AMPK pathway. Am J Physiol Endocrinol Metab 2012; 302:E1560-1568.
34. Prieto-Hontoria PL, Perez-Matute P, Fernandez-Galilea M, Martinez JA, Moreno-Aliaga MJ. Lipoic acid inhibits leptin secretion and Sp1 activity in adipocytes. Mol Nutr Food Res 2011; 55:1059-1069.
35. Prieto-Hontoria PL, Fernandez-Galilea M, Perez-Matute P, Martinez JA, Moreno-Aliaga MJ. Lipoic acid inhibits adiponectin production in 3T3-L1 adipocytes. J Physiol Biochem 2013; 69:595-600.
36. Moini H, Tirosh O, Park YC, Cho KJ, Packer L. R-alpha-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes. Arch Biochem Biophys 2002; 397:384-391.
37. Shen W, Hao J, Feng Z, et al. Lipoamide or lipoic acid stimulates mitochondrial biogenesis in 3T3-L1 adipocytes via the endothelial NO synthase-cGMP-protein kinase G signalling pathway. Br J Pharmacol 2011; 162:1213-1224.
38. Maddux BA, See W, Lawrence JC, Jr., Goldfine AL, Goldfine ID, Evans JL. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of alpha-lipoic acid. Diabetes 2001; 50:404-410.
39. Carlson DA, Smith AR, Fischer SJ, Young KL, Packer L. The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects. Altern Med Rev 2007; 12:343-351.
40. Park KG, Min AK, Koh EH, et al. Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways. Hepatology 2008; 48:1477-1486.